Pure Global AI
NCT06227793Recruiting

Pragmatic Clinical Trial to Assess the Effectiveness of Pharmaceutical Intervention in Patients With Uncontrolled Asthma

Hospital de Clinicas de Porto AlegreClinicalTrials.govbehavioral
Study focus
Disease/Condition
Asthma
Drug/Device/Intervention
pharmaceutical intervention
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Hospital de Clinicas de Porto Alegre
Location
Porto Alegre, Brazil
Timeline & enrollment
Phase
N/A
Start date
Aug 14, 2023
End date
Mar 30, 2026
Enrollment
76 participants
Primary outcome

Asthma control

Summary

The aim of this study is to evaluate the effectiveness of pharmaceutical intervention in
 controlling asthma in patients diagnosed with uncontrolled asthma. This is a pragmatic
 clinical trial composed of two groups - intervention (pharmaceutical monitoring) and control
 (without pharmaceutical monitoring). The study population will consist of patients with
 uncontrolled asthma, seen at the asthma outpatient clinic of the Hospital de Clínicas de
 Porto Alegre. Patients who agree to participate in the study will be randomized to the
 control group (managed by the specialized outpatient medical team) and the intervention group
 (in addition to management by the specialized medical team, they will be referred for
 pharmaceutical monitoring at the Clinical Research Center of the Hospital de Clínicas de
 Porto Alegre). The primary outcome of the study will be the proportion of patients with
 uncontrolled asthma who achieve an ACT 20 after a systematic educational intervention,
 guided by a pharmaceutical professional, compared to a group that does not receive this type
 of intervention.

ICD-10 classifications
AsthmaAsthma, unspecifiedNonallergic asthmaMixed asthmaPredominantly allergic asthma
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06227793
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06227793 through Pure Global AI's free database. This phase not specified trial is sponsored by Hospital de Clinicas de Porto Alegre and is currently Recruiting. The study focuses on Asthma. Target enrollment is 76 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.